Status:
COMPLETED
CCRC: Understanding the Effects of Omega-3 Fatty Acids Versus Lignans in Flaxseed on Metabolic and Inflammatory Markers Leading to Diabetes and Cardiovascular Disease
Lead Sponsor:
University of California, Davis
Collaborating Sponsors:
Flax Canada 2015 Inc.
Conditions:
Body Weight
Lipids
Eligibility:
All Genders
40-65 years
Phase:
NA
Brief Summary
The aim of this study is to compare the effects of flaxseed on atherogenic lipids, plasma inflammatory markers, and insulin sensitivity. We hypothesize that flaxseed omega-3 fatty acids will improve ...
Eligibility Criteria
Inclusion
- Men or postmenopausal women in the 40-65 years age range. Body Mass Index in the range of 25-39
Exclusion
- Women are are premenopausal
- Smoking
- Diabetes
- Cancer
- Gout
- Untreated thyroid disease
- Kidney Disease
- Liver Disease
- Use of lipid lowering drugs
- Use of insulin sensitizing drugs
- Use of ACE inhibitors or other blood pressure lowering medications
- Use of over the counter or prescription anti-obesity medications
- Weight loss of 10% or more within the last 12 months
Key Trial Info
Start Date :
February 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2010
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT00935922
Start Date
February 1 2009
End Date
April 1 2010
Last Update
October 29 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CCRC
Mather, California, United States, 95655